STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] Organon & Co. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

The Vanguard Group filed an amended Schedule 13G reporting beneficial ownership of 35,927,524 shares of Organon & Co. common stock, representing 13.82% of the class as of the stated event date 09/30/2025. Vanguard reports 0 shares with sole voting power, 1,689,621 with shared voting power, 33,922,797 with sole dispositive power, and 2,004,727 with shared dispositive power.

The filing classifies Vanguard as an investment adviser and includes the standard certification that the securities were acquired and are held in the ordinary course of business and not to change or influence control. Vanguard notes its clients have rights to dividends or sale proceeds related to the reported securities, with no single client interest exceeding five percent.

Positive
  • None.
Negative
  • None.

Insights

Routine 13G/A disclosing a 13.82% passive stake in OGN.

The Vanguard Group reports beneficial ownership of 35,927,524 shares of Organon & Co., or 13.82% of the class, tied to the event date 09/30/2025. Voting power is largely shared or through dispositive authority: sole voting 0, shared voting 1,689,621, sole dispositive 33,922,797, shared dispositive 2,004,727.

The certification states the holdings are in the ordinary course and not for influencing control, consistent with a passive Schedule 13G filing by an investment adviser. Clients of Vanguard have rights to dividends or proceeds; no single client exceeds five percent of the class.

This is primarily informational regarding ownership concentration. Actual impact depends on portfolio flows and holder decisions; the filing does not specify transactions or strategic intent beyond passive ownership.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:10/30/2025
ORGANON & CO

NYSE:OGN

OGN Rankings

OGN Latest News

OGN Latest SEC Filings

OGN Stock Data

1.75B
259.05M
0.25%
84.6%
5.74%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
JERSEY CITY